PCI Pal has launched its new secure integration with Epic healthcare software. Epic is the leading electronic healthcare record (EHR) software provider in the US, serving close to half of all hospitals. The integration will enable users of Epic software to take secure payments from within Epic applications, improving compliance and reducing friction. This is an important step in the company’s plan to expand in the US, with the healthcare market offering significant potential for new business.

At its recent capital markets day, PCI Pal reiterated its growth strategy as it transforms from a secure payment solutions provider to a multi-product secure engagement platform. With the ambition to become a ‘rule of 40’ company in the medium term, the company outlined the steps it is taking to maintain annual recurring revenue (ARR) growth of 18–20%. This includes a combination of winning new partners and enterprise customers, geographic expansion and expanding the product range to cover more of a customer’s engagement with a contact centre, whether human or AI bot interaction. Profit growth is expected to come from revenue drop through and operational improvements such as self-service deployments and reduction in time to revenue for deployments.

PCI Pal is a provider of cloud-based secure payment technology to the business communications market. The company has grown annual recurring revenue (ARR) at a fast pace over the last five years, helped by its channel-first strategy. After several years fighting patent litigation, which was ultimately resolved in PCI Pal’s favour in June 2024, the company is accelerating the pace of investment to drive ARR growth. The two areas for additional investment are marketing, both general and product related, to drive deeper engagement with key partners and attract more direct enterprise business; and product development to support the company’s plans to expand the product range and increase net revenue retention. Our ARR forecasts are in line with PCI Pal’s growth targets (18–20% to FY27 and beyond). We forecast a drop in EBITDA margins in FY26 to 2.8% as the extra investment is made, growing to 8.2% in FY27.